Home

Schizophrenia

Congress highlights

Do men and women experience psychiatric disorders differently?

There are several known epidemiological differences between the genders in psychiatric disorders....

The neurobiology of conversion to psychosis – emerging findings from the SHARP study

The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to...

Real-world evidence — raising organizational fluency through interactive learning techniques

Real-world evidence (RWE) demonstrates long-term effectiveness and safety beyond the efficacy and...

Congress highlights

Core components of the Coordinated Specialty Care model for first-episode psychosis

The Coordinated Specialty Care (CSC) model for first-episode psychosis (FEP) is an evidence-based...

Social and cognitive interventions that improve outcomes for patients with psychosis

A 3-month critical time intervention service involving social workers and peer specialists to...

Congress highlights

How are genes involved in tailoring psychiatric treatment?

Psychiatrists need an understanding of genome-wide association studies (GWAS), pharmacogenomics,...

Congress highlights

Can blue-depleted light decrease duration of psychiatric hospitalization?

Novel light and sensor technologies have been installed in a new acute psychiatric unit in Norway...

Congress highlights

The new technologies transforming psychiatric practice and patient outcomes

Data-driven approaches to psychiatric diagnosis and practice fueled by the abundance of information...

Satellite symposium

Are relapse prevention and functioning sufficiently prioritized in the treatment of schizophrenia?

Improving adherence and reducing rates of relapse and rehospitalization are of paramount importance...

Video #8: Initiation of long-acting injectable antipsychotic treatment in patients with schizophrenia

Video #7: Long-acting injectable antipsychotics in the treatment plan of patients with schizophrenia

Satellite symposium

Treatment outcomes in schizophrenia – what matters to patients?

Schizophrenia treatment has moved from mainly addressing relapse prevention and symptom suppression...

Medical education resource center

Lundbeck Institute Campus

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind South East Asia Continue to Progress in Mind South Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan Continue to Progress in Mind България Continue to Progress in Mind Israel

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind South Africa
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in South Africa click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

Accept

Decline